EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2019 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
XGN on Nasdaq
Shares outstanding
21,684,000
Price per share
$6.08
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
9,051,420
Total reported value
$99,471,224
% of total 13F portfolios
0%
Share change
-107,068
Value change
+$1,739,498
Number of holders
62
Price from insider filings
$6.08
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NMSIC Co-Investment Fund, L.P. 9.8% -18% $10,289,904 -$2,047,500 1,758,958 -17% NMSIC Co-Investment Fund, L.P. 25 Mar 2025
RTW INVESTMENTS, LP 7.7% $11,589,595 1,696,866 RTW Investments, LP 30 Jun 2025
Cowen Financial Products LLC 5% $5,214,491 891,366 Cowen Financial Products LLC 31 Mar 2025
LYTTON LAURENCE W 1% $1,481,017 216,840 LYTTON LAURENCE W 30 Jun 2025

As of 30 Sep 2025, 62 institutional investors reported holding 9,051,420 shares of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN). This represents 42% of the company’s total 21,684,000 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) together control 37% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
RTW INVESTMENTS, LP 7.8% 1,696,866 0% 0.23% $18,648,557
VANGUARD GROUP INC 3.4% 733,824 +7.7% 0% $8,064,726
Balyasny Asset Management L.P. 3.3% 723,428 +0.65% 0.02% $7,950,474
Invesco Ltd. 3.1% 675,192 0% $7,420,360
KENNEDY CAPITAL MANAGEMENT LLC 2.5% 551,848 +78% 0.13% $6,064,810
SILVERCREST ASSET MANAGEMENT GROUP LLC 2.4% 519,468 -2.3% 0.04% $5,708,953
WEXFORD CAPITAL LP 2.1% 444,927 +6.9% 1.5% $4,889,750
MILLENNIUM MANAGEMENT LLC 1.1% 247,173 0% $2,716,431
TWO SIGMA INVESTMENTS, LP 1.1% 237,979 +278% 0% $2,615,389
Russell Investments Group, Ltd. 1.1% 229,115 +3.9% 0% $2,517,970
FourWorld Capital Management LLC 1% 227,000 +8.9% 6% $2,494,730
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.93% 202,150 0% $2,221,629
Manatuck Hill Partners, LLC 0.81% 175,000 0% 0.65% $1,923,250
Massar Capital Management, LP 0.78% 170,000 0% 0.67% $1,868,300
GEODE CAPITAL MANAGEMENT, LLC 0.75% 163,255 +11% 0% $1,794,683
AMERIPRISE FINANCIAL INC 0.59% 128,348 +35% 0% $1,410,545
Informed Momentum Co LLC 0.54% 117,558 +20% 0.15% $1,291,962
CITADEL ADVISORS LLC 0.54% 116,230 0% $1,277,368
ACADIAN ASSET MANAGEMENT LLC 0.52% 113,830 +803% 0% $1,249,000
JANE STREET GROUP, LLC 0.47% 102,307 0% $1,124,354
Huntleigh Advisors, Inc. 0.43% 93,353 +6.3% 0.17% $1,025,949
EHP Funds Inc. 0.42% 90,807 1.3% $997,969
UBS Group AG 0.42% 90,011 -80% 0% $989,221
TWO SIGMA ADVISERS, LP 0.39% 84,100 0% $924,259
BlackRock, Inc. 0.38% 82,367 +1.1% 0% $905,213

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 13,430 $81,654 -$39,398 $6.08 1
2025 Q3 9,051,420 $99,471,224 +$1,739,498 $10.99 62
2025 Q2 9,111,690 $63,597,819 +$21,426,288 $6.98 52
2025 Q1 6,236,997 $22,405,746 +$385,252 $3.59 38
2024 Q4 6,113,043 $25,062,839 -$538,498 $4.10 40
2024 Q3 6,394,043 $19,757,785 +$369,366 $3.09 33
2024 Q2 6,285,386 $11,440,080 +$146,598 $1.82 32
2024 Q1 6,204,754 $9,866,115 -$618,718 $1.59 30
2023 Q4 6,593,813 $13,122,186 -$539,993 $1.99 30
2023 Q3 6,865,400 $16,672,879 -$40,169 $2.42 29
2023 Q2 6,882,688 $19,959,393 +$147,220 $2.90 28
2023 Q1 6,831,965 $16,602,559 -$244,590 $2.43 26
2022 Q4 6,935,251 $16,645,632 -$2,305,522 $2.40 29
2022 Q3 7,861,041 $21,300,458 -$231,631,208 $2.71 34
2022 Q2 10,719,847 $277,184,000 -$6,862,755 $5.74 43
2022 Q1 9,090,221 $72,994,000 +$3,569,328 $8.03 53
2021 Q4 8,601,668 $100,004,000 -$2,767,380 $11.63 52
2021 Q3 8,781,775 $119,557,457 +$1,312,484 $13.60 53
2021 Q2 8,613,995 $129,154,810 -$7,053,554 $14.99 54
2021 Q1 8,946,764 $156,282,938 +$75,898,347 $17.50 57
2020 Q4 4,249,160 $55,964,160 +$2,491,490 $13.20 34
2020 Q3 4,277,910 $46,956,000 +$8,095,924 $10.84 33
2020 Q2 3,607,852 $44,703,000 -$5,870,542 $12.40 32
2020 Q1 3,874,615 $61,755,000 -$13,974,986 $15.94 32
2019 Q4 3,845,028 $97,663,000 +$14,413,406 $25.40 36
2019 Q3 3,584,885 $55,529,000 +$55,529,001 $15.49 27